Daihan Pharmaceutical Co.,Ltd.
Financials
Valuation Metrics
Daihan Pharmaceutical Co.,Ltd.'s Market Cap is ₩1578B. At end of 2025 it was ₩1755B. Ranked #953 of 2,436 in KR market (top 39%), #457 of 1,649 on KOSDAQ (top 28%), #110 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 47%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 157.80B KRW | KR#953/2,436 Sec#110/234 |
| Revenue | 211.44B KRW | KR#986/2,436 Sec#54/234 |
| Net Income | 26.98B KRW | KR#544/2,436 Sec#38/234 |
| Total Assets | 352.90B KRW | KR#921/2,436 Sec#57/234 |
| Net Assets | 301.16B KRW | KR#699/2,436 Sec#46/234 |
| Employees | 675 | KR#370/2,436 Sec#30/234 |
| Value | ||
| P/E | 5.85x | KR#364/2,436 Sec#15/234 |
| P/B | 0.52x | KR#849/2,436 Sec#37/234 |
| P/S | 0.75x | KR#1,202/2,436 Sec#61/234 |
| EV/EBITDA | 3.71x | KR#126/2,436 Sec#2/234 |
| FCF Yield | 0.31% | KR#1,195/2,436 Sec#89/234 |
| Profitability | ||
| ROE | 8.96% | KR#594/2,436 Sec#36/234 |
| ROA | 7.64% | KR#372/2,436 Sec#28/234 |
| Op. Margin | 14.10% | KR#305/2,436 Sec#27/234 |
| Revenue Growth | 5.66% | KR#1,137/2,436 Sec#105/234 |
| Earnings Growth | -8.70% | KR#975/2,436 Sec#64/234 |
| Financial Health | ||
| Debt Ratio | 117.18% | KR#595/2,436 Sec#77/234 |
| Total Debt | 0 KRW | KR—/2,436 Sec—/234 |
| FCF | 481.5M KRW | KR#1,187/2,436 Sec#91/234 |
| Cash | 47.15B KRW | KR#781/2,436 Sec#49/234 |
| Current Ratio | 3.61x | KR#493/2,436 Sec#77/234 |
| Net Debt/EBITDA | -1.58x | KR#355/2,436 Sec#19/234 |
| Dividend | ||
| Div. Yield | 3.82% | KR#464/2,436 Sec#15/234 |
| Div. Growth | 11.11% | KR#554/2,436 Sec#31/234 |
| Performance | ||
| 1Y Return | -17.03% | KR#1,173/2,436 Sec#92/234 |
| 1M Return | 1.74% | KR#710/2,436 Sec#61/234 |
| From 52W High | -18.95% | KR#172/2,436 Sec#7/234 |
| 1Y MDD | -27.74% | KR#157/2,436 Sec#8/234 |
| Trading | ||
| Volume | 6,532 shares | KR#2,220/2,436 Sec#219/234 |
| Foreign Own. | 20.04% | KR#225/2,436 Sec#9/234 |
| Per Share | ||
| EPS | 4,496 KRW | KR#190/2,436 Sec#13/234 |
| BPS | 51,218 KRW | KR#234/2,436 Sec#17/234 |
Company Info
Established in 1963 and listed on KOSDAQ in 1994, Daehan Pharm is a specialty pharmaceutical company manufacturing and selling infusion solutions. It primarily produces infusion solutions, ampoules, and nutritional solutions for medical facilities, and also enters the pharmacy market with OTC products like contact lens cleaning solutions. The company has established a mass production system and pursues cost reduction through continuous infrastructure development, including automated production lines and warehouses. Daehan Pharm's headquarters are located in Yeongdeungpo-gu, Seoul.